The Pharmaceutical Journal
Vol 274 No 7335 p139
5 February 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Related websites
Consultation letter (PDF 75K)
Online response form

Pepto-Bismol reclassification

Procter & Gamble has asked the Medicines and Healthcare products Regulatory Agency to reclassify Pepto-Bismol as a general sale list medicine. Consultation on the request is open until 25 February.